Tower Research Capital LLC (Trc) Theratechnologies Inc. Transaction History

Tower Research Capital LLC (Trc)

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.98 - $2.42 $10,545 - $12,888	-5,326 Reduced 82.5%	1,130 $3,000
Q2 2022 Aug 15, 2022	BUY	$2.21 - $2.7 $4,722 - $5,769	2,137 Added 49.48%	6,456 $15,000
Q1 2022 May 12, 2022	SELL	$2.37 - $3.24 $4,415 - $6,036	-1,863 Reduced 30.14%	4,319 $11,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $3.76 $17,298 - $22,274	5,924 Added 2296.12%	6,182 $19,000
Q3 2021 Nov 15, 2021	BUY	$3.28 - $4.07 $846 - $1,050	258 New	258 $1,000
Q1 2021 May 17, 2021	SELL	$2.2 - $3.94 $5,847 - $10,472	-2,658 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$1.91 - $2.5 $5,076 - $6,645	2,658 New	2,658 $6,000
Q3 2020 Nov 16, 2020	SELL	$1.96 - $2.92 $2,548 - $3,796	-1,300 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$1.58 - $2.86 $5,530 - $10,010	-3,500 Reduced 72.92%	1,300 $3,000
Q1 2020 May 15, 2020	BUY	$1.43 - $3.23 $6,864 - $15,504	4,800 New	4,800 $8,000

29.2K

Ticker THTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 95,141,600
Market Cap $116M
Description
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with l...

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.